Abstract
Repeated administration of growth hormone secretagogues (GHSs) has proven to be a delicate matter owing to development of tolerance. The aim of the present study was to define conditions during which the responsiveness to the orally active NN703 was maintained over several days. Growing pigs were fitted with stomach and vascular catheters, permitting unstressed intragastric administrations and blood sampling. NN703 or vehicle was administered once daily. When NN703 was given at a dose of 18 mg/kg, there was a massive acute increase in plasma growth hormone (GH) levels, but this was only seen on the first day of administration. A dose of 1.8 mg/kg did not cause a significant acute increase in plasma GH concentrations, whereas stimulation of pulsatile GH release was sustained over a 4-d period. During the first 7 h following injection of vehicle, the area under the curve of plasma GH was 1211 ± 144 (µg/[L·7 h]), but increased to 1770 ± 269 and 1824 ± 198 (µg/[L·7 h]) on the first and fourth day of NN703 administration, respectively. Deconvolution analysis of the 7-h profiles revealed that the GH mass per burst as well as the GH burst amplitude were significantly (p < 0.001) increased during treatment with NN703, which led to an increase in pulsatile GH secretion rate (p < 0.001). Insulin-like growth factor-1 plasma concentrations increased steadily during NN703 administration (p < 0.01) and decreased after termination of treatment. The sustained increase in GH pulsatility observed with low-dose NN703 treatment suggests that development of tolerance to this GHS may be obviated by minimization of dose.
Similar content being viewed by others
References
Smith, R. G., Van der Ploeg, L. H., Howard A. D., Feighner, S. D., Cheng, K., Hickey, G. J., Wyvratt, M. J. Jr., Fisher, M. H., Nargund, R. P., and Patchett, A. A. (1997). Endocr. Rev. 18, 621–645.
Hansen, T. K., Ankersen, M., Hansen, B. S., Raun, K., Nielsen, K. K., Lau, J., Peschke, B., Lundt, B. F., Thogersen, H., Johansen, N. L., Madsen, K., and Andersen, P. H. (1998). J. Med. Chem. 41, 3705–3714.
Smith, R. G., Palyha, O. C., Feighner, S. D., Tan, C. P., McKee, K. K., Hreniuk, D. L., Yang, L., Morriello, G., Nargund, R., Patchett, A. A., and Howard, A. D. (1999). Horm. Res. 51, 1–8.
Hansen, B. S., Raun, K., Nielsen, K. K., Johansen, P. B., Hansen, T. K., Peschke, B., Lau, J., Andersen, P. H., and Ankersen, M. (1999). Eur. J. Endocrinol. 141, 180–189.
Ankersen, M., Nielsen K. K., Hansen, T. K., Raun, K., and Hansen, B. S. (2000). Eur. J. Med. Chem. 35, 487–497.
Momany, F. A., Bowers, C. Y., Reynolds, G. A., Chang, D., Hong, A., and Newlander, K. (1981). Endocrinology 108, 31–39.
Dickson, S. L., Leng, G., Dyball, R. E., and Smith, R. G. (1995). Neuroendocrinology 61, 36–43.
Cheng, K., Chan, W. W., Barreto, A., Convey, E. M., and Smith, R. G. (1989). Endocrinology 124, 2791–2798.
Howard, A. D., Feighner, S. D., Cully, D. F., et al. (1996). Science 273, 974–977.
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K. (1999). Nature 402, 656–660.
Date, Y., Murakami, N., Kojima, M., Kuroiwa, T., Matsukura, S., Kangawa, K., and Nakazato, M. (2000). Biochem. Biophys. Res. Commun. 275, 477–480.
Seoane, L. M., Tovar, S., Baldelli, R., Arvat, E., Ghigo, E., Casanueva, F. F., and Dieguez, C. (2000). Eur. J. Endocrinol. 143, R007-R009.
Nakazato M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., and Matsukura, S. (2001). Nature 409, 194–198.
Chen, C. (2000). Clin. Exp. Pharmacol. Physiol. 27, 323–329.
Fletcher, T. P., Thomas, G. B., and Clarke, I. J. (1996). Domest. Anim. Endocrinol. 13, 251–258.
Bowers, C. Y., Reynolds, G. A., Durham, D., Barrera, C. M., Pezzoli, S. S., and Thorner, M. O. (1990). J. Clin. Endocrinol. Metab. 70, 975–982.
Blake, A. D. and Smith, R. G. (1991). J. Endocrinol. 129, 11–19.
Klinger, B., Silbergeld, A., Deghenghi, R., Frenkel, J., and Laron, Z. (1996). Eur. J. Endocrinol. 134, 716–719.
Hickey, G. J., Jacks, T. M., Schleim, K. D., Frazier, E., Chen, H. Y., Krupa, D., Feeney, W., Nargund, R. P., Patchett, A. A., and Smith, R. G. (1997). J. Endocrinol. 152, 183–192.
Zdravkovic, M., Sogaard, B., Ynddal, L., Christiansen, T., Agerso, H., Thomsen, M. S., Falch, J. E., and Ilondo, M. M. (2000). Growth Horm. IGF Res. 10, 193–198.
McDowell, R. S., Elias, K. A., Stanley, M. S., Burdick, D. J., Burnier, J. P., Chan, K. S., Fairbrother, W. J., Hammonds, R. G., Ingle, G. S., and Jacobsen, N. E. (1995). Proc. Natl. Acad. Sci. USA 92, 11,165–11,169.
Guan, X. M., Yu, H., Palyha, O. C., McKee, K. K., Feighner, S. D., Sirinathsinghji, D. J., Smith, R. G., Van der Ploeg, L. H., and Howard, A. D. (1997). Mol. Brain Res. 48, 23–29.
Bailey, A. R., Giles, M., Brown, C. H., Bull, P. M., Macdonald, L. P., Smith, L. C., Smith, R. G., Leng, G., and Dickson, S. L. (1999). Neuroendocrinology 70, 83–92.
Bennett, P. A., Thomas, G. B., Howard, A. D., Feighner, S. D., Van der Ploeg, L. H., Smith, R. G., and Robinson, I. C. (1997). Endocrinology 138, 4552–4557.
Nass, R., Gilrain, J., Anderson, S., Gaylinn, B., Dalkin, A., Day, R., Peruggia, M., and Thorner, M. O. (2000). Endocrinology 141, 2084–2089.
Sato, M., Chihara, K., Kita, T., Kashio, Y., Okimura, Y., Kitajima, N., and Fujita, T. (1989). Neuroendocrinology 50, 139–151.
Chapman, I. M., Pescovitz, O. H., Murphy, G., Treep, T., Cerchio, K. A., Krupa, D., Gertz, B., Polvino, W. J., Skiles, E. H., Pezzoli, S. S., and Thorner, M. O. (1997). J. Clin. Endocrinol. Metab. 82, 3455–3463.
Chapman, I. M., Hartman, M. L., Pezzoli, S. S., and Thorner, M. O. (1996). J. Clin. Endocrinol. Metab. 81, 2874–2880.
Shah, N., Evans, W. S., Bowers, C. Y., and Veldhuis, J. D. (1999). J. Clin. Endocrinol. Metab. 84, 2140–2150.
Svensson, J., Wiklund, O., and Ottosson, M., Johannsson, G., Taskinen, M. R., Wiklund, O., and Bengtsson, B. A. (1999). J. Clin. Endocrinol. Metab. 84, 2028–2033.
Malmlof, K., Cortova, Z., Saxerholt, H., Karlsson, E., Arrhenius-Nyberg, V., and Skottner, A. (1995). Clin. Sci. (Colch.) 88, 285–292.
Raun, K., Hansen, B. S., Johansen, N. L., Thogersen, H., Madsen, K., Ankersen, M., and Andersen, P. H. (1998). Eur. J. Endocrinol. 139, 552–561.
Malmlof, K., Johansen, P. B., Haahr, P. M., Wilken, M., and Oxlund, H. (1999). Growth Horm. IGF Res. 9, 445–450.
Veldhuis, J. D. and Johnson, M. L. (1992). Methods Enzymol. 210, 539–575.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Malmlöf, K., Bauer, M.K., Johansen, P.B. et al. Daily low-dose administration of growth hormone secretagogue stimulates pulsatile growth hormone secretion and elevates plasma insulin-like growth factor-1 levels in pigs. Endocr 16, 195–199 (2001). https://doi.org/10.1385/ENDO:16:3:195
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:16:3:195